Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

US Patent 10001483 · Granted Jun 19, 2018

Estimated economic value: $428,319,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for treating and preventing extracellular histone mediated pathologies2025
Compounds for treating and preventing net associated complications2025
Compounds for treating and preventing extracellular histone mediated pathologies2023
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2022
Methods of treating myelodysplastic syndromes with a combination therapy using l2021
PDE4 modulators for treating and preventing immune reconstitution inflammatory s2020
PDE4 modulators for treating and preventing immune reconstitution inflammatory s2020
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2019
Methods of treating myelodysplastic syndromes using lenalidomide2018
Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-2017
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione f2016
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and he2016